PVI
OCDX

Pura Vida Investments’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Pura Vida Investments’s Portfolio OCDX Stock Details OCDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-550,000
Closed -$10.2M – 337
2021
Q3 		$10.2M Buy
+550,000
New +$11.1M 0.31% 82
2021
Q2 		– Sell
-413,891
Closed -$7.99M – 299
2021
Q1 		$7.99M Buy
+413,891
New +$7.29M 0.23% 91

Other funds holding OCDX

CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Pura Vida Investments's OCDX Position: Q4 2021 in Review

Pura Vida Investments sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q4 2021, closing a stake of 550,000 shares — an estimated $10.2M sold.

Pura Vida Investments first reported a position in OCDX in Q1 2021 and held it in 2 quarters. The position peaked at $10.2M in Q3 2021. 162 funds tracked by Wall St. Rank hold OCDX as of Q4 2021.

  • Pura Vida Investments reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q4 2021 after selling out during the quarter.
  • Pura Vida Investments sold 550,000 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q4 2021, an estimated $10.2M.
  • Pura Vida Investments first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 2 quarters.
  • Pura Vida Investments's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $10.2M in Q3 2021.
  • 162 funds tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q4 2021.

Based on Pura Vida Investments's 13F filing for Q4 2021, filed 14 Feb 2022.